跳转至内容
Merck
CN
  • The ubiquitin ligase TRIM56 inhibits ovarian cancer progression by targeting vimentin.

The ubiquitin ligase TRIM56 inhibits ovarian cancer progression by targeting vimentin.

Journal of Cellular Physiology (2018)
Zhao L, et al.